Development of Enthesopathies and Joint Structural Damage in a Murine Model of X-Linked Hypophosphatemia

被引:15
作者
Faraji-Bellee, Carole-Anne [1 ]
Cauliez, Axelle [1 ]
Salmon, Benjamin [1 ,2 ]
Fogel, Olivier [3 ,4 ]
Zhukouskaya, Volha [1 ,5 ]
Benoit, Aurelie [6 ]
Schinke, Thorsten [7 ]
Roux, Christian [3 ,4 ]
Linglart, Agnes [5 ,8 ,9 ]
Miceli-Richard, Corinne [3 ,4 ]
Chaussain, Catherine [1 ,2 ,5 ]
Briot, Karine [3 ,4 ,5 ]
Bardet, Claire [1 ]
机构
[1] Univ Paris, Sch Dent, Lab Orofacial Pathol Imaging & Biotherapies, UR 2496, Montrouge, France
[2] Bretonneau Hosp, AP HP, Reference Ctr Rare Disorders Calcium & Phosphate, Dept Dent Med, Paris, France
[3] Univ Paris, Dept Rheumatol, Cochin Hosp, Reference Ctr Rare Disorders Calcium & Phosphate, Paris, France
[4] Cochin Hosp, Reference Ctr Rare Genet Bone Dis, Paris, France
[5] Bicetre Paris Sud Hosp, AP HP, Ctr Rare Disorders Calcium & Phosphate Metab, Filiere OSCAR & Platform Expertise Rare Dis Paris, Le Kremlin Bicetre, France
[6] Univ Paris, Sch Dent, UR 4462, URB21, Montrouge, France
[7] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, Hamburg, Germany
[8] Bicetre Paris Sud Hosp, AP HP, Dept Endocrinol & Diabetol Children, Le Kremlin Bicetre, France
[9] Paris Sud Paris Saclay Univ, Fac Med, Le Kremlin Bicetre, France
来源
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2020年 / 8卷
关键词
Hypmouse; natural history; enthesophyte; joint alteration; XLH; MINERALIZATION; OSTEOPONTIN; PHOSPHATE; THERAPY; RICKETS; GROWTH; ADULTS; BONE; PHEX; CALCITRIOL;
D O I
10.3389/fcell.2020.00854
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
X-linked hypophosphatemia (XLH) is characterized by rickets and osteomalacia, caused by inactivating mutations in the Phosphate-regulating endopeptidase homolog X-linked (PHEX) gene. With aging, adult patients develop paradoxical heterotopic calcifications of tendons and ligaments at their insertion sites (enthesophytes), and joint alterations. Understanding the progression of this structural damage that severely affects patients' quality of life will help to improve the management of XLH. Here, we characterized the occurrence of enthesophytes and joint alterations through a 12 monthin vivomicro-CT follow-up in theHypmouse, a murine model of XLH (n= 5 mice per group). Similar to adult patients with XLH,Hypmice developed calcaneal enthesophytes, hip joint alterations, erosions of the sacroiliac joints and periarticular calcifications. These lesions were already present at month 3 and gradually worsened over time. In sharp contrast, no abnormalities were observed in control mice at early time points. Histological analyses confirmed the presence of bone erosions, calcifications and expansion of mineralizing enthesis fibrocartilage inHypmice and their absence in controls and suggested that new bone formation is driven by altered mechanical strain. Interestingly, despite a strong deformation of the curvature, none of theHypmice displayed enthesophyte at the spine. Peripheral enthesophytes and joint alterations develop at the early stages of the disease and gradually worsen overtime. Overall, our findings highlight the relevance of this preclinical model to test new therapies aiming to prevent bone and joint complications in XLH.
引用
收藏
页数:13
相关论文
共 44 条
[1]   Phosphorylation-Dependent Inhibition of Mineralization by Osteopontin ASARM Peptides Is Regulated by PHEX Cleavage [J].
Addison, William N. ;
Masica, David L. ;
Gray, Jeffrey J. ;
McKee, Marc D. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2010, 25 (04) :695-705
[2]   Effects of Crotalus durissus collilineatus venom in the isolated rat kidney [J].
Amora, DN ;
Sousa, TM ;
Martins, AMC ;
Barbosa, PSF ;
Magalhaes, MR ;
Toyama, MH ;
Fonteles, MC ;
de Menezes, DB ;
Monteiro, HSA .
TOXICON, 2006, 47 (03) :260-264
[3]   Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia [J].
Barros, Nilana M. T. ;
Hoac, Betty ;
Neves, Raquel L. ;
Addison, William N. ;
Assis, Diego M. ;
Murshed, Monzur ;
Carmona, Adriana K. ;
McKee, Marc D. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (03) :688-699
[4]  
Bergwitz C, 2009, ENDOCR DEV, V16, P133, DOI 10.1159/000223693
[5]   Osteoporitin and the dento-osseous pathobiology of X-linked hypophosphatemia [J].
Boukpessi, Tchilalo ;
Hoac, Betty ;
Coyac, Benjamin R. ;
Leger, Thibaut ;
Garcia, Camille ;
Wicart, Philippe ;
Whyte, Michael P. ;
Glorieux, Francis H. ;
Linglart, Agnes ;
Chaussain, Catherine ;
McKee, Marc D. .
BONE, 2017, 95 :151-161
[6]   Abnormal Presence of the Matrix Extracellular Phosphoglycoprotein-Derived Acidic Serine- and Aspartate-Rich Motif Peptide in Human Hypophosphatemic Dentin [J].
Boukpessi, Tchilalo ;
Gaucher, Celine ;
Leger, Thibaut ;
Salmon, Benjamin ;
Le Faouder, Julie ;
Willig, Cyril ;
Rowe, Peter S. ;
Garabedian, Michele ;
Meilhac, Olivier ;
Chaussain, Catherine .
AMERICAN JOURNAL OF PATHOLOGY, 2010, 177 (02) :803-812
[7]   Sclerostin Antibody Treatment Increases Bone Mass and Normalizes Circulating Phosphate Levels in Growing Hyp Mice [J].
Carpenter, Kelsey A. ;
Ross, Ryan D. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 (03) :596-607
[8]   Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia [J].
Carpenter, Thomas O. ;
Imel, Erik A. ;
Ruppe, Mary D. ;
Weber, Thomas J. ;
Klausner, Mark A. ;
Wooddell, Margaret M. ;
Kawakami, Tetsuyoshi ;
Ito, Takahiro ;
Zhang, Xiaoping ;
Humphrey, Jeffrey ;
Insogna, Karl L. ;
Peacock, Munro .
JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (04) :1587-1597
[9]   The expanding family of hypophosphatemic syndromes [J].
Carpenter, Thomas O. .
JOURNAL OF BONE AND MINERAL METABOLISM, 2012, 30 (01) :1-9
[10]   A Clinician's Guide to X-Linked Hypophosphatemia [J].
Carpenter, Thomas O. ;
Imel, Erik A. ;
Holm, Ingrid A. ;
de Beur, Suzanne M. Jan ;
Insogna, Karl L. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (07) :1381-1388